000			03636nam a22004215i 4500
999			_c383693 _d383693
001			383693
003			ES-MaUEC
005			20230102122142.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			201126s2021 sz | s |||| 0|eng d
020			_a9783030548599
024	7		_a10.1007/978-3-030-54859-9 _2doi
040			_bspa _cES-MaUEC _dES-MaUEC
050		4	_aRL321 _b2021 EB
245	0	0	_aAdvances in Psoriasis : _bA Multisystemic Guide _cedited by Jeffrey M. Weinberg, Mark Lebwohl
250			_a2nd edition 2021
264		1	_aCham _bSpringer International Publishing _c2021
300			_a1 recurso en línea (VI, 423 páginas) _b54 ilustraciones, 45 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_aarchivo de texto _bPDF
505	0		_aIntroduction to and History of Psoriasis and Psoriasis Therapy -- Pathophysiology of Psoriasis/Novel Pathways -- Psoriasis: Clinical Review and Update -- Psoriasis: Epidemiology, Potential Triggers, Disease Course -- Topical Therapy I: Corticosteroids and Vitamin D Analogues -- Topical Therapy II: Retinoids, Immunomodulators, and Others -- Topical Therapy II: Retinoids, Immunomuodulators, and Others/ Ultraviolet Therapy for Psoriasis -- Laser Therapy for Psoriasis -- Traditional Systemic Therapy I: Methotrexate and Cyclosporine -- Traditional Systemic Therapy II: Retinoids and Others -- Apremilast -- Etanercept -- Adalimumab -- Infliximab, Golimumab , and Certolizumab Pegol -- Ustekinumab -- Guselkumab -- Tidrakizumab -- Risankizumab -- Secukinumab -- Ixekizumab -- Brodalumab -- Biosimilars for Psoriasis -- Research Pipeline I: Oral Therapeutics for Psoriasis -- Research Pipeline II: Upcoming Biologic Therapies -- Pediatric Psoriasis -- Challenges in Psoriasis Treatment: Nail, Scalp, and Palmoplantar Involvement -- Psoriasis and Comorbidities -- Summary of Published Treatment Guidelines -- Index.
520	3		_aThis extensively revised second edition provides an up-to-date and highly informative textbook on psoriasis. The understanding of the mechanisms behind the disease and the available treatment options have continued to develop rapidly in recent times, with this vital resource covering the latest in these management options, including targeted T-cell therapy, the use of immunomodulators, systemic therapies, and ultraviolet and laser therapy. In addition, it provides a detailed overview of the pathophysiology, comorbidities, epidemiology and triggers of the disease. Advances in Psoriasis: A Multisystemic Guide extensively details the scientific basis and practice management of psoriasis. It is therefore a vital resource for practicing and trainee dermatologists looking to develop their clinical knowledge of how to manage and treat these patients.
988			_aSpringer_Medicine_2021
650		7	_2embne _9139920 _aPsoriasis
700	1		_aWeinberg, Jeffrey M. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aLebwohl, Mark _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
776	0	8	_iPrinted edition: _z9783030548582
776	0	8	_iPrinted edition: _z9783030548605
776	0	8	_iPrinted edition: _z9783030548612
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-54859-9 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b11/2022 _dz _eu _zSI